Reengineering inducible cardiac-specific transgenesis with an attenuated myosin heavy chain promoter

Circulation Research

Volumn 92, Issue 6, 2003, Pages 609-616

  Sanbe, Atsushi ^a   Gulick, James ^a   Hanks, Mark C ^b   Liang, Qiangrong ^a   Osinska, Hanna ^a   Robbins, Jeffrey ^a  

^a CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^b PROCTER AND GAMBLE PHARMACEUTICALS   (United States)

Author keywords

Cardiac disease; Mice; Muscle; Myosin; Transgene

Indexed keywords

CONTRACTILE PROTEIN; GLYCOGEN SYNTHASE KINASE 3BETA; MUSCLE PROTEIN; MYOSIN HEAVY CHAIN; MYOSIN LIGHT CHAIN; TRANSACTIVATOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CODON; CONTROLLED STUDY; DNA SPLICING; ENZYME INDUCTION; GENE EXPRESSION; GENE LOCUS; GENETIC ENGINEERING; HEART HYPERTROPHY; HEART VENTRICLE OVERLOAD; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSACTIVATION; TRANSGENE; TRANSGENICS;

ANIMALS; CARDIOMEGALY; DNA, COMPLEMENTARY; GENETIC ENGINEERING; GLYCOGEN SYNTHASE KINASE 3; HERPES SIMPLEX VIRUS PROTEIN VMW65; MICE; MICE, TRANSGENIC; MYOCARDIUM; MYOSIN HEAVY CHAINS; MYOSIN LIGHT CHAINS; PROMOTER REGIONS (GENETICS); RNA SPLICING; SARCOMERES; SEQUENCE DELETION; TETRACYCLINE; TRANS-ACTIVATION (GENETICS); TRANSGENES;

EID: 0037418939     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000065442.64694.9F     Document Type: Article

References (36)

1. Chien KR. Genomic circuits and the integrative biology of cardiac diseases. Nature. 2000;407:227-232.
2. Valancius V, Smithies O. Testing an "in-out" targeting procedure for making subtle genomic modifications in mouse embryonic stem cells. Mol Cell Biol. 1991;11:1402-1408.
3. Chen J, Kubalak SW, Chien KR. Ventricular muscle-restricted targeting of the RXRα gene reveals a non-cell-autonomous requirement in cardiac chamber morphogenesis. Development. 1998;125:1943-1949.
4. Sohal DS, Nghiem M, Crackower MA, Witt SA, Kimball TR, Tymitz KM, Penninger JM, Molkentin JD. Temporally regulated and tissue-specific gene manipulations in the adult and embryonic heart using a tamoxifen-inducible Cre protein. Circ Res. 2001;89:20-25.
5. Izumo S, Shioi T. Cardiac transgenic and gene-targeted mice as models of cardiac hypertrophy and failure: a problem of (new) riches. J Card Fail. 1998;4:263-270.
6. Ng WA, Grupp IL, Subramaniam A, Robbins J. Cardiac myosin heavy chain mRNA expression and myocardial function in the mouse heart. Circ Res. 1991;68:1742-1750.
7. Wang Y, O'Malley BW, Tsai SY. Inducible system designed for future gene therapy. Methods Mol Biol. 1997;63:401-413.
8. Bujard H. Controlling genes with tetracyclines. J Gene Med. 1999;1:372-374.
9. Furth PA, St Onge L, Boger H, Gruss P, Gossen M, Kistner A, Bujard H, Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA. 1994; 91:9302-9306.
10. Mansuy IM, Bujard H. Tetracycline-regulated gene expression in the brain. Curr Opin Neurobiol. 2000;10:593-596.
11. Freundlieb S, Schirra-Muller C, Bujard H. A tetracycline controlled activation/repression system with increased potential for gene transfer into mammalian cells. J Gene Med. 1999;1:4-12.
12. Yu Z, Redfern CS, Fishman GI. Conditional transgene expression in the heart. Circ Res. 1996;79:691-697.
13. Redfern CH, Coward P, Degtyarev MY, Lee EK, Kwa AT, Hennighausen L, Bujard H, Fishman GI, Conklin BR. Conditional expression and signaling of a specifically designed Gi-coupled receptor in transgenic mice. Nat Biotechnol. 1999;17:165-169.
14. Fishman GI, Kaplan ML, Buttrick PM. Tetracycline-regulated cardiac gene expression in vivo. J Clin Invest. 1994;93:1864-1868.
15. Bowman JC, Steinberg SF, Jiang TR, Geenen DL, Fishman GI, Buttrick PM. Expression of protein kinase Cβ in the heart causes hypertrophy in adult mice and sudden death in neonates. J Clin Invest. 1997;100: 2189-2195.
16. Dor Y, Camenisch TD, Itin A, Fishman GI, McDonald JA, Carmeliet P, Keshet E. A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects. Development. 2001;128:1531-1538.
17. Suzuki J, Shen WJ, Nelson BD, Patel S, Veerkamp JH, Selwood SP, Murphy GM Jr, Reaven E, Kraemer FB. Absence of cardiac lipid accumulation in transgenic mice with heart-specific HSL overexpression. Am J Physiol. 2001;281:E857-E866.
18. Valencia TG, Roberts LD, Zeng H, Grant SR. Tetracycline-inducible CaM kinase II silences hypertrophy-sensitive gene expression in rat neonate cardiomyocytes. Biochem Biophys Res Commun. 2000;274:803-810.
19. Gossen M, Bonin AL, Freundlieb S, Bujard H. Inducible gene expression systems for higher eukaryotic cells. Curr Opin Biotechnol. 1994;5:516-520.
20. Valencik ML, McDonald JA. Codon optimization markedly improves doxycycline regulated gene expression in the mouse heart. Transgenic Res. 2001;10:269-275.
21. Gossen M, Bujard H. Efficacy of tetracycline-controlled gene expression is influenced by cell type: commentary. Biotechniques. 1995;19:213-217.
22. Gossen M, Freundlieb S, Bender G, Muller G, Hillen W, Bujard H. Transcriptional activation by tetracyclines in mammalian cells. Science. 1995;268:1766-1769.
23. Baron U, Gossen M, Bujard H. Tetracycline-controlled transcription in eukaryotes: novel transactivators with graded transactivation potential. Nucleic Acids Res. 1997;25:2723-2729.
24. Urlinger S, Baron U, Thellmann M, Hasan MT, Bujard H, Hillen W. Exploring the sequence space for tetracycline-dependent transcriptional activators: novel mutations yield expanded range and sensitivity. Proc Natl Acad Sci U S A. 2000;97:7963-7968.
25. Subramaniam A, Gulick J, Neumann J, Knotts S, Robbins J. Transgenic analysis of the thyroid-responsive elements in the a-cardiac myosin heavy chain gene promoter. J Biol Chem. 1993;268:4331-4336.
26. Rindt H, Subramaniam A, Robbins J. An in vivo analysis of transcriptional elements in the mouse α-myosin heavy chain gene promoter. Transgenic Res. 1995;4:397-405.
27. Huang WY, Liew CC. A conserved GATA motif in a tissue-specific DNase I hypersensitive site of the cardiac a-myosin heavy chain gene. Biochem J. 1997;325:47-51.
28. Molkentin JD, Kalvakolanu DV, Markham BE. Transcription factor GATA-4 regulates cardiac muscle-specific expression of the α-myosin heavy chain gene. Mol Cell Biol. 1994;14:4947-4957.
29. Sanbe A, Fewell JG, Gulick J, Osinska H, Lorenz J, Hall DG, Murray LA, Kimball TR, Witt SA, Robbins J. Abnormal cardiac structure and function in mice expressing nonphosphorylatable cardiac regulatory myosin light chain 2. J Biol Chem. 1999;274:21085-21094.
30. Robbins J. Altering cardiac function via transgenesis: a nuts and bolts approach. Trends Cardiovasc Med. 1997;7:185-191.
31. Jones WK, Sanchez A, Robbins J. Murine pulmonary myocardium: developmental analysis of cardiac gene expression. Dev Dyn. 1994;200: 117-128.
32. Gulick J, Hewett TE, Klevitsky R, Buck SH, Moss RL, Robbins J. Transgenic remodeling of the regulatory myosin light chains in the mammalian heart. Circ Res. 1997;80:655-664.
33. Palermo J, Gulick J, Colbert M, Fewell J, Robbins J. Transgenic remodeling of the contractile apparatus in the mammalian heart. Circ Res. 1996;78:504-509.
34. Eldar-Finkelman H. Glycogen synthase kinase 3: an emerging therapeutic target. Trends Mol Med. 2002;8:126-132.
35. Hardt SE, Sadoshima J. Glycogen synthase kinase-3β: a novel regulator of cardiac hypertrophy and development. Circ Res. 2002;90:1055-1063.
36. Antos CL, McKinsey TA, Frey N, Kutschke W, McAnally J, Shelton JM, Richardson JA, Hill JA, Olson EN. Activated glycogen synthase-3β suppresses cardiac hypertrophy in vivo. Proc Natl Acad Sci U S A. 2002; 99:907-912.